In a different example, TWIST has been shown to recruit DNMT3B to the estrogen receptor 1 (ESR1) promoter, resulting in DNAme and loss of ER expression, and the progression of breast cancers that are ER-negative and hormone-resistant (24). This evidence concerns the gene ESR1 and breast carcinoma.